Form 4: Biodesix CAO Sells Shares for Tax Obligations

Biodesix's Chief Accounting Officer, Chris Vazquez, reported the sale of 101 common shares at an average price of $10.0841 to cover tax obligations related to RSU vesting.

Summary

• Chris Vazquez, Chief Accounting Officer of Biodesix Inc. (BDSX), reported transactions involving company common stock.
• On February 9, 2026, 263 shares of common stock were acquired, likely due to the vesting of Restricted Stock Units (RSUs).
• On February 10, 2026, 101 shares of common stock were sold at a weighted average price of $10.0841 per share.
• This sale was an automatic disposition to cover tax obligations arising from the vesting of RSUs.
• The shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive.
• Following these transactions, Chris Vazquez beneficially owns 1,234 shares of Biodesix common stock directly.
• The RSU numbers have been adjusted to reflect a one-for-twenty reverse stock split effective September 15, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While it's a sale by an insider, it's explicitly for tax purposes related to RSU vesting, which is a common and expected occurrence, not necessarily signaling a lack of confidence.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates continued employee retention and long-term incentive alignment for a key executive.

Negatives

• The sale of shares, even for tax purposes, reduces the direct ownership stake of a key executive in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales for tax purposes upon RSU vesting are a routine occurrence across all industries, particularly in high-growth sectors like biotechnology where equity compensation is a significant component of executive pay. These transactions are generally not indicative of a change in management's long-term outlook for the company.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is for tax purposes and represents a small percentage of total outstanding shares. It provides transparency into executive compensation and ownership.
• Employees: The RSU vesting indicates the company's ongoing use of equity compensation, which can be a positive for employee retention and alignment.

Key Dates

Recommendation

The reported transactions are routine insider sales to cover tax obligations upon RSU vesting, which is a common practice and does not typically reflect a change in the executive's long-term view of the company. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' recommendation.

Keywords

Biodesix, BDSX, Chris Vazquez, Form 4, Insider Trading, Stock Sale, RSU Vesting, Chief Accounting Officer, Equity Compensation, Tax Obligations